SCHEMBL7007730

SCHEMBL7007730

COc1c(Cc2ccc(Cl)c(Cl)c2)cc2ccccc2c1CN1CCC(=O)NCC1=O

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CCR2 P41597 1/20 0.36
▸ KMT2A Q03164 3/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ ATM Q13315 2/20 0.34
▸ GAA P10253 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ NPBWR1 P48145 1/20 0.34
▸ SIGMAR1 Q99720 1/20 0.33
▸ CCR3 P51677 1/20 0.33
▸ SLC6A2 P23975 2/20 0.32
▸ SLC6A4 P31645 2/20 0.32
▸ SLC6A3 Q01959 2/20 0.32
▸ CXCR3 P49682 1/20 0.32
▸ ADORA2A P29274 1/20 0.32
▸ HCRTR1 O43613 1/20 0.32
▸ HCRTR2 O43614 1/20 0.32
▸ RCE1 Q9Y256 1/20 0.32
▸ TACR2 P21452 1/20 0.32
▸ MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5234914 0.70 CYP2C9 (0.41) KMT2AMEN1ATMGAASIGMAR1
SCHEMBL5232211 0.69 MEN1 (0.43) KMT2AMEN1ATMNPBWR1CCR3
SCHEMBL7094297 0.66 BCHE (0.42) KMT2AMEN1TDP1TACR2MAPT
SCHEMBL5232904 0.66 TACR2 (0.39) TDP1NPBWR1SIGMAR1CCR3CXCR3
SCHEMBL5232741 0.64 XIAP (0.37) KMT2AMEN1CCR3HCRTR1HCRTR2
SCHEMBL5232732 0.64 XIAP (0.37) KMT2AMEN1CCR3HCRTR1HCRTR2
SCHEMBL5232940 0.62 TACR2 (0.43) KMT2AMEN1TDP1SIGMAR1CXCR3
SCHEMBL5229554 0.62 TACR2 (0.43) KMT2AMEN1TDP1SIGMAR1CXCR3
SCHEMBL5235259 0.61 NPBWR1 (0.38) KMT2AMEN1ATMNPBWR1CCR3
SCHEMBL5237322 0.60 CLPP (0.45) GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1296961-A1 1,4-DIAZEPAN-2,5-DIONE DERIVATIVES AND THEIR USE AS NK-1 RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2003-04-02 — — EP disclosed
WO-2001090083-A1 1,4-DIAZEPAN-2,5-DIONE DERIVATIVES AND THEIR USE AS NK-1 RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2001-11-29 — — WO disclosed
Send feedback